Straube Richard 4
4 · SOLIGENIX, INC. · Filed Dec 12, 2025
Insider Transaction Report
Form 4
SOLIGENIX, INC.SNGX
Straube Richard
Sr VP & Chief Medical Officer
Transactions
- Award
Option (Right to Buy)
2025-12-11+10,000→ 10,000 totalExercise: $1.63From: 2025-12-11Exp: 2035-12-10→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The stock option vested immediately as to 25% of the shares and vests as to the remaining 75% of the shares in 12 equal installments (or nearly equal installments if the number of remaining shares is not evenly divisible by 12) on each three (3) month anniversary of December 11, 2025.